Clinical Trial Details
EORTC-20982-LYMG
Back to Clinical Trials Database
Prospective controlled trial in clinical stages I-II supradiaphragmatic Hodgkin'Disease. Evaluation of treatment efficacy, (long term) toxicity and Quality of Life in two different prognostic subgroups.
| Trial Status | LT-FU ongoing |
|---|---|
| Dates |
Date of activation: 15-Oct-1998 Date Step1 close: 14-May-2004 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 1626 |
| Treatment |
Radiotherapy, Drug |
| Study Staff |
Marie-Ange Lentz (Data Manager) , EORTC Headquarters, Brussels Laurens Vinckier (Pharmacovigilance Manager) , EORTC Headquarters, Brussels |
| Type of cancer | Hodgkins Disease |
| Participating groups | EORTC Lymphoma Group |
| Centers to be activated | Centre Hospitalier Princesse Grace (Monaco, Monaco) |
| Protocol summary | http://clinicaltrials.gov/study/NCT00005584 |
| NCT number | NCT00005584 |
| Financial Support | EORTC HQ |
